NOVONIX Ltd Files 6-K With Appendix 3G Notification
Ticker: NVNXF · Form: 6-K · Filed: May 2, 2025 · CIK: 1859795
| Field | Detail |
|---|---|
| Company | Novonix Ltd (NVNXF) |
| Form Type | 6-K |
| Filed Date | May 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, notification-of-issue, sec-filing
Related Tickers: NVX
TL;DR
NOVONIX filed a 6-K with an Appendix 3G - likely a share issuance or change in holdings.
AI Summary
NOVONIX Limited filed a Form 6-K on May 2, 2025, reporting an Appendix 3G notification of issue. The filing is for the month of May 2025 and is submitted under the 1934 Securities Exchange Act. NOVONIX Limited is incorporated in Australia and has its principal executive office in Brisbane.
Why It Matters
This filing indicates a change in shareholding or issuance of new securities by NOVONIX Ltd, which could impact its stock structure and investor base.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a notification of issue, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- May 2, 2025 (date) — Filing Date
- Appendix 3G (document) — Included Exhibit
FAQ
What is the purpose of the Appendix 3G mentioned in the filing?
The Appendix 3G is a notification of issue, typically related to changes in substantial holdings or the issuance of new securities.
What is the filing date of this Form 6-K?
The filing date is May 2, 2025.
Under which SEC Act is this report filed?
This report is filed under the Securities Exchange Act of 1934.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Does NOVONIX Limited file annual reports under Form 20-F or 40-F?
NOVONIX Limited files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 2, 2025 regarding NOVONIX Ltd (NVNXF).